Phase 2 Study of Orally Formulated Heat-killed Mycobacterium Vaccae Study in TB Patients.

Trial Profile

Phase 2 Study of Orally Formulated Heat-killed Mycobacterium Vaccae Study in TB Patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Oct 2013

At a glance

  • Drugs Mycobacterium vaccae vaccine (Primary)
  • Indications Pulmonary tuberculosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Aug 2012 Actual end date (Aug 2012) added as reported by ClinicalTrials.gov.
    • 01 Aug 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Aug 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top